The effect of iron in MRI and transverse relaxation of amyloid-beta plaques in Alzheimer's disease.
Mark D Meadowcroft, Douglas G Peters, Rahul P Dewal, James R Connor, Qing X Yang
Index: NMR Biomed. 28(3) , 297-305, (2015)
Full Text: HTML
Abstract
Dysregulation of neural iron is known to occur during the progression of Alzheimer's disease. The visualization of amyloid-beta (Aβ) plaques with MRI has largely been credited to rapid proton relaxation in the vicinity of plaques as a result of focal iron deposition. The goal of this work was to determine the relationship between local relaxation and related focal iron content associated with Aβ plaques. Alzheimer's disease (n=5) and control tissue (n=3) sample slices from the entorhinal cortex were treated overnight with the iron chelator deferoxamine or saline, and microscopic gradient-echo MRI datasets were taken. Subsequent to imaging, the same slices were stained for Aβ and iron, and then compared with regard to parametric R2 * relaxation maps and gradient-echo-weighted MR images. Aβ plaques in both chelated and unchelated tissue generated MR hypo-intensities and showed relaxation rates significantly greater than the surrounding tissue. The transverse relaxation rate associated with amyloid plaques was determined not to be solely a result of iron load, as much of the relaxation associated with Aβ plaques remained following iron chelation. The data indicate a dual relaxation mechanism associated with Aβ plaques, such that iron and plaque composition synergistically produce transverse relaxation.Copyright © 2014 John Wiley & Sons, Ltd.
Related Compounds
Related Articles:
2015-04-01
[Acta Physiol. (Oxf.) 213(4) , 902-19, (2015)]
2015-02-11
[J. Neurosci. 35(6) , 2384-97, (2015)]
2014-09-01
[PLoS Genet. 10(9) , e1004659, (2014)]
2014-12-01
[Tissue Eng. Part A 20(23-24) , 3163-75, (2014)]
2015-01-01
[Arch. Toxicol. 89(1) , 107-19, (2015)]